Literature DB >> 29915456

Retinoblastoma: a curable, rare and deadly blinding disease.

Richard Bowman1.   

Abstract

Entities:  

Year:  2018        PMID: 29915456      PMCID: PMC5998401     

Source DB:  PubMed          Journal:  Community Eye Health        ISSN: 0953-6833


× No keyword cloud information.
Every year, thousands of babies and children in low- and middle-income countries lose their sight and their lives to a treatable childhood eye cancer called retinoblastoma; usually because it was not recognised and treated in time. Early diagnosis and treatment can save the life of a child with retinoblastoma. INDIA Although retinoblastoma is relatively uncommon, it can have devastating consequences for the children affected by it. If treated too late, it can lead to the loss of the eye, invasion of the brain and death. Retinoblastoma does not affect everyone equally. In high-income countries, fewer than 5% of children die as a result of the condition, thanks to early diagnosis and specialist treatment. In Africa, however, it is typical to see 70% of children with retinoblastoma die, mainly because they presented too late. When mothers do present at a tertiary centre with a child who has advanced retinoblastoma, they often report that they have had several interactions with different health professionals over many months or even years, but did not get the referral or care they needed. Every health professional reading this issue of the Community Eye Health Journal has a chance to redress this balance. We need to find and treat children with retinoblastoma early, before it causes disfigurement or death. Doing so successfully requires adopting a multidisciplinary, multi-level and internationally collaborative approach that looks at the health system as a whole (see page 4). Raising awareness of retinoblastoma in the community, improving the detection and diagnosis of the condition, setting up good referral systems and offering good counselling and high quality treatment (including good prosthetics) are all needed to increase the uptake of services and save lives.

Ministry of health

Ministries of health have the power to made dramatic improvements to the early detection and treatment of retinoblastoma. They can: Create public health campaigns to raise awareness that ‘seeing something white’ inside a child's eye is a medical emergency Include basic ocular history taking and eye examination techniques in the curriculum of community nurses Offer subsidised access to specialist treatment for children with this life-threatening condition. Parents must be made aware that they should seek help urgently if they see something white inside their child's eyes. Emphasise that parents should not let their child be turned away and must not take ‘no’ for an answer if they feel there is something wrong.

A worthwhile investment

Investing resources in the early detection and referral of children with retinoblastoma has wider benefits in the fields of childhood blindness in low- and middle-income countries, as the same criteria (something white in the eye) will also help with the early detection of childhood cataract. Late presentation of childhood cataract is the leading cause of treatable blindness in children, and is entirely preventable if cataracts are detected and treated in time.

In the community

Nurses and health workers seeing children in the community can check children's eyes during routine immunisation appointments, for example. Something abnormal, white or shiny, or a squint, may be the first sign of retinoblastoma and requires urgent specialist referral. Listen to the parents and/or carers. If they have seen something white or abnormal in their child's eye, believe what they say, take it seriously and seek specialist advice. Public health awareness campaigns can support the early detection of retinoblastoma INDIA In Tanzania, community nurses have been trained to examine the red reflex (p. 23) using an Arclight ophthalmoscope. The Arclight is an affordable, solar-powered and easy-to-use ophthalmoscope. It has shown preliminary promise; the community nurses found it easy to learn and began picking up cases of cataract and retinoblastoma by using it. Nurses can learn how to examine the red reflex at the same time as examining the child's other systems.

Tertiary centres

At tertiary centres, histopathologists have a crucial role: once the eye is removed the child may be able to leave hospital completely cured or may need chemotherapy or radiotherapy; this decision must be based on accurate histopathological staging (page 18).

International collaboration

To promote this multi-level, multi-disciplinary and internationally collaborative approach, the Commonwealth Eye Health Consortium has provided start-up funding for an Rb-Network known as Rb-NET, which has already generated specific country plans, a set of core outcome indicators, best practice protocols and a practical resource manual (). Basic clinical research questions still need to be answered. For instance, researchers in Uganda have shown an improvement in survival by giving chemotherapy before surgery on the basis that so many children have extra-ocular spread at time of presentation. On the other hand, a small study from Tanzania showed that 60% of children for whom there was good histology after enucleation had complete excision of the tumour with low risk and never needed chemotherapy. So which should come first in these settings - chemotherapy or surgery? By combining multi-centre and multi-country clinical research, as Rb-NET has started to do, we can begin to answer these questions and prevent needless tragedies. This issue of the Journal demonstrates that there is real momentum and determination to improve outcomes for children with Rb in all countries across the world. It contains concise, practical information that should help all of us to make a difference. Roles and responsibilities in the detection, referral and treatment of retinoblastoma Abby White Chief Executive: World Eye Cancer Hope UK Patients with retinoblastoma are first and foremost children who happen to have cancer in their eye(s). Defining a child as a ‘case’ dehumanises them and draws attention away from thoughts about their complete wellbeing and that of their family. A child with retinoblastoma is not a medical specimen. They are a complete individual with thoughts, feelings, hopes, dreams, likes and dislikes. They have the ability to generate every kind of emotion in those who care for them. They are desperately loved, and most parents would give their own eye if it could spare their child's suffering. In evaluating different treatments, we must weigh the value of each treatment in relation to the child's complete wellbeing. We must look beyond the physical body to embrace and care for the child's emotional health, during therapy and long after into adulthood. Perhaps if we collectively take care to consider ‘children’, ‘families’ and ‘survivors’ rather than ‘cases’, we will together establish a level ground on which we can both treat the cancer, and heal the spirit in equal measure to set the child up for a healthy, happy future. Rb-NET website Resource manual Arclight
Table 1

Roles and responsibilities in the detection, referral and treatment of retinoblastoma

Individual responsibilities
Parent →Health worker/nurse →Ophthalmologist →Specialist eye centre
Seek help urgently if you see something white inside the centre of the eye (the pupil) OR if you take a photograph and only one eye has a red dot in the centreDo not let anyone turn you away and do not take no for an answer until a doctor at a hospital has examined the child's eyes using a bright lightBelieve the parents if they say they have seen something white inside the pupil and seek specialist advice. Treat it as a medical emergencyLearn how to test the red reflex (p. 23). Test all children during routine visits and immunisationsLearn to recognise retinoblastoma and to identify eyes that need enucleationCounsel parents about the good cosmetic outcomes of enucleation with implantation. Show pictures of children with good outcomesLearn how to enucleate, taking more than 15 mm of optic nerve. Always examine the fundus of the fellow eye when you perform an enucleation: there could be a small tumour which is treatable by laserRefer all children with signs of retinoblastoma in two eyes to a national or specialist centre for urgent treatmentSame as for ophthalmologists, plus:Learn how to give focal or laser treatment to smaller tumours (usually in the second eye)Create multidisciplinary teams who work closely together to coordinate the treatment of each childInclude in this team: ophthalmologists, oncologists, histopathologists, nurses, child life specialists or play therapists and/or counsellorsOffer general and genetic counselling to parents/carersRefer parents to other sources of support for their child's learning and development
The Ministry of Health's responsibilities towards the above
Run public awareness campaigns so that parents know that treatment is possible and know when to see a doctorEnsure that the red reflex test (p. 23) is included in the curriculum for nurses and health workersEnsure there is at least one ophthalmologist per 100,000 populationSupport the development of national retinoblastoma centres and referral networks. Offer subsidised access to specialist treatment for all children with retinoblastoma. Provide screening services for siblings and accommodation or travel subsidies for the parents or carers of these young children.
  2 in total

1.  Global Retinoblastoma Presentation and Analysis by National Income Level.

Authors:  Ido Didi Fabian; Elhassan Abdallah; Shehu U Abdullahi; Rula A Abdulqader; Sahadatou Adamou Boubacar; Dupe S Ademola-Popoola; Adedayo Adio; Armin R Afshar; Priyanka Aggarwal; Ada E Aghaji; Alia Ahmad; Marliyanti N R Akib; Lamis Al Harby; Mouroge H Al Ani; Aygun Alakbarova; Silvia Alarcón Portabella; Safaa A F Al-Badri; Ana Patricia A Alcasabas; Saad A Al-Dahmash; Amanda Alejos; Ernesto Alemany-Rubio; Amadou I Alfa Bio; Yvania Alfonso Carreras; Christiane Al-Haddad; Hamoud H Y Al-Hussaini; Amany M Ali; Donjeta B Alia; Mazin F Al-Jadiry; Usama Al-Jumaily; Hind M Alkatan; Charlotta All-Eriksson; Ali A R M Al-Mafrachi; Argentino A Almeida; Khalifa M Alsawidi; Athar A S M Al-Shaheen; Entissar H Al-Shammary; Primawita O Amiruddin; Romanzo Antonino; Nicholas J Astbury; Hatice T Atalay; La-Ongsri Atchaneeyasakul; Rose Atsiaya; Taweevat Attaseth; Than H Aung; Silvia Ayala; Baglan Baizakova; Julia Balaguer; Ruhengiz Balayeva; Walentyna Balwierz; Honorio Barranco; Covadonga Bascaran; Maja Beck Popovic; Raquel Benavides; Sarra Benmiloud; Nissrine Bennani Guebessi; Rokia C Berete; Jesse L Berry; Anirban Bhaduri; Sunil Bhat; Shelley J Biddulph; Eva M Biewald; Nadia Bobrova; Marianna Boehme; H C Boldt; Maria Teresa B C Bonanomi; Norbert Bornfeld; Gabrielle C Bouda; Hédi Bouguila; Amaria Boumedane; Rachel C Brennan; Bénédicte G Brichard; Jassada Buaboonnam; Patricia Calderón-Sotelo; Doris A Calle Jara; Jayne E Camuglia; Miriam R Cano; Michael Capra; Nathalie Cassoux; Guilherme Castela; Luis Castillo; Jaume Català-Mora; Guillermo L Chantada; Shabana Chaudhry; Sonal S Chaugule; Argudit Chauhan; Bhavna Chawla; Violeta S Chernodrinska; Faraja S Chiwanga; Tsengelmaa Chuluunbat; Krzysztof Cieslik; Ruellyn L Cockcroft; Codruta Comsa; Zelia M Correa; Maria G Correa Llano; Timothy W Corson; Kristin E Cowan-Lyn; Monika Csóka; Xuehao Cui; Isac V Da Gama; Wantanee Dangboon; Anirban Das; Sima Das; Jacquelyn M Davanzo; Alan Davidson; Patrick De Potter; Karina Q Delgado; Hakan Demirci; Laurence Desjardins; Rosdali Y Diaz Coronado; Helen Dimaras; Andrew J Dodgshun; Craig Donaldson; Carla R Donato Macedo; Monica D Dragomir; Yi Du; Magritha Du Bruyn; Kemala S Edison; I Wayan Eka Sutyawan; Asmaa El Kettani; Amal M Elbahi; James E Elder; Dina Elgalaly; Alaa M Elhaddad; Moawia M Ali Elhassan; Mahmoud M Elzembely; Vera A Essuman; Ted Grimbert A Evina; Zehra Fadoo; Adriana C Fandiño; Mohammad Faranoush; Oluyemi Fasina; Delia D P G Fernández; Ana Fernández-Teijeiro; Allen Foster; Shahar Frenkel; Ligia D Fu; Soad L Fuentes-Alabi; Brenda L Gallie; Moira Gandiwa; Juan L Garcia; David García Aldana; Pascale Y Gassant; Jennifer A Geel; Fariba Ghassemi; Ana V Girón; Zelalem Gizachew; Marco A Goenz; Aaron S Gold; Maya Goldberg-Lavid; Glen A Gole; Nir Gomel; Efren Gonzalez; Graciela Gonzalez Perez; Liudmira González-Rodríguez; Henry N Garcia Pacheco; Jaime Graells; Liz Green; Pernille A Gregersen; Nathalia D A K Grigorovski; Koffi M Guedenon; D Sanjeeva Gunasekera; Ahmet K Gündüz; Himika Gupta; Sanjiv Gupta; Theodora Hadjistilianou; Patrick Hamel; Syed A Hamid; Norhafizah Hamzah; Eric D Hansen; J William Harbour; M Elizabeth Hartnett; Murat Hasanreisoglu; Sadiq Hassan; Shadab Hassan; Stanislava Hederova; Jose Hernandez; Lorelay Marie Carcamo Hernandez; Laila Hessissen; Diriba F Hordofa; Laura C Huang; G B Hubbard; Marlies Hummlen; Kristina Husakova; Allawi N Hussein Al-Janabi; Russo Ida; Vesna R Ilic; Vivekaraj Jairaj; Irfan Jeeva; Helen Jenkinson; Xunda Ji; Dong Hyun Jo; Kenneth P Johnson; William J Johnson; Michael M Jones; Theophile B Amani Kabesha; Rolande L Kabore; Swathi Kaliki; Abubakar Kalinaki; Mehmet Kantar; Ling-Yuh Kao; Tamar Kardava; Rejin Kebudi; Tomas Kepak; Naama Keren-Froim; Zohora J Khan; Hussain A Khaqan; Phara Khauv; Wajiha J Kheir; Vikas Khetan; Alireza Khodabande; Zaza Khotenashvili; Jonathan W Kim; Jeong Hun Kim; Hayyam Kiratli; Tero T Kivelä; Artur Klett; Jess Elio Kosh Komba Palet; Dalia Krivaitiene; Mariana Kruger; Kittisak Kulvichit; Mayasari W Kuntorini; Alice Kyara; Eva S Lachmann; Carol P S Lam; Geoffrey C Lam; Scott A Larson; Slobodanka Latinovic; Kelly D Laurenti; Bao Han A Le; Karin Lecuona; Amy A Leverant; Cairui Li; Ben Limbu; Quah Boon Long; Juan P López; Robert M Lukamba; Livia Lumbroso; Sandra Luna-Fineman; Delfitri Lutfi; Lesia Lysytsia; George N Magrath; Amita Mahajan; Abdul Rahim Majeed; Erika Maka; Mayuri Makan; Emil K Makimbetov; Chatonda Manda; Nieves Martín Begue; Lauren Mason; John O Mason; Ibrahim O Matende; Miguel Materin; Clarissa C D S Mattosinho; Marchelo Matua; Ismail Mayet; Freddy B Mbumba; John D McKenzie; Aurora Medina-Sanson; Azim Mehrvar; Aemero A Mengesha; Vikas Menon; Gary John V D Mercado; Marilyn B Mets; Edoardo Midena; Divyansh K C Mishra; Furahini G Mndeme; Ahmed A Mohamedani; Mona T Mohammad; Annette C Moll; Margarita M Montero; Rosa A Morales; Claude Moreira; Prithvi Mruthyunjaya; Mchikirwa S Msina; Gerald Msukwa; Sangeeta S Mudaliar; Kangwa I Muma; Francis L Munier; Gabriela Murgoi; Timothy G Murray; Kareem O Musa; Asma Mushtaq; Hamzah Mustak; Okwen M Muyen; Gita Naidu; Akshay Gopinathan Nair; Larisa Naumenko; Paule Aïda Ndoye Roth; Yetty M Nency; Vladimir Neroev; Hang Ngo; Rosa M Nieves; Marina Nikitovic; Elizabeth D Nkanga; Henry Nkumbe; Murtuza Nuruddin; Mutale Nyaywa; Ghislaine Obono-Obiang; Ngozi C Oguego; Andrzej Olechowski; Scott C N Oliver; Peter Osei-Bonsu; Diego Ossandon; Manuel A Paez-Escamilla; Halimah Pagarra; Sally L Painter; Vivian Paintsil; Luisa Paiva; Bikramjit P Pal; Mahesh Shanmugam Palanivelu; Ruzanna Papyan; Raffaele Parrozzani; Manoj Parulekar; Claudia R Pascual Morales; Katherine E Paton; Katarzyna Pawinska-Wasikowska; Jacob Pe'er; Armando Peña; Sanja Peric; Chau T M Pham; Remezo Philbert; David A Plager; Pavel Pochop; Rodrigo A Polania; Vladimir G Polyakov; Manca T Pompe; Jonathan J Pons; Daphna Prat; Vireak Prom; Ignatius Purwanto; Ali O Qadir; Seema Qayyum; Jiang Qian; Ardizal Rahman; Salman Rahman; Jamalia Rahmat; Purnima Rajkarnikar; Rajesh Ramanjulu; Aparna Ramasubramanian; Marco A Ramirez-Ortiz; Léa Raobela; Riffat Rashid; M Ashwin Reddy; Ehud Reich; Lorna A Renner; David Reynders; Dahiru Ribadu; Mussagy M Riheia; Petra Ritter-Sovinz; Duangnate Rojanaporn; Livia Romero; Soma R Roy; Raya H Saab; Svetlana Saakyan; Ahmed H Sabhan; Mandeep S Sagoo; Azza M A Said; Rohit Saiju; Beatriz Salas; Sonsoles San Román Pacheco; Gissela L Sánchez; Phayvanh Sayalith; Trish A Scanlan; Amy C Schefler; Judy Schoeman; Ahad Sedaghat; Stefan Seregard; Rachna Seth; Ankoor S Shah; Shawkat A Shakoor; Manoj K Sharma; Sadik T Sherief; Nandan G Shetye; Carol L Shields; Sorath Noorani Siddiqui; Sidi Sidi Cheikh; Sónia Silva; Arun D Singh; Niharika Singh; Usha Singh; Penny Singha; Rita S Sitorus; Alison H Skalet; Hendrian D Soebagjo; Tetyana Sorochynska; Grace Ssali; Andrew W Stacey; Sandra E Staffieri; Erin D Stahl; Christina Stathopoulos; Branka Stirn Kranjc; David K Stones; Caron Strahlendorf; Maria Estela Coleoni Suarez; Sadia Sultana; Xiantao Sun; Meryl Sundy; Rosanne Superstein; Eddy Supriyadi; Supawan Surukrattanaskul; Shigenobu Suzuki; Karel Svojgr; Fatoumata Sylla; Gevorg Tamamyan; Deborah Tan; Alketa Tandili; Fanny F Tarrillo Leiva; Maryam Tashvighi; Bekim Tateshi; Edi S Tehuteru; Luiz F Teixeira; Kok Hoi Teh; Tuyisabe Theophile; Helen Toledano; Doan L Trang; Fousseyni Traoré; Sumalin Trichaiyaporn; Samuray Tuncer; Harba Tyau-Tyau; Ali B Umar; Emel Unal; Ogul E Uner; Steen F Urbak; Tatiana L Ushakova; Rustam H Usmanov; Sandra Valeina; Milo van Hoefen Wijsard; Adisai Varadisai; Liliana Vasquez; Leon O Vaughan; Nevyana V Veleva-Krasteva; Nishant Verma; Andi A Victor; Maris Viksnins; Edwin G Villacís Chafla; Vicktoria Vishnevskia-Dai; Tushar Vora; Antonio E Wachtel; Werner Wackernagel; Keith Waddell; Patricia D Wade; Amina H Wali; Yi-Zhuo Wang; Avery Weiss; Matthew W Wilson; Amelia D C Wime; Atchareeya Wiwatwongwana; Damrong Wiwatwongwana; Charlotte Wolley Dod; Phanthipha Wongwai; Daoman Xiang; Yishuang Xiao; Jason C Yam; Huasheng Yang; Jenny M Yanga; Muhammad A Yaqub; Vera A Yarovaya; Andrey A Yarovoy; Huijing Ye; Yacoub A Yousef; Putu Yuliawati; Arturo M Zapata López; Ekhtelbenina Zein; Chengyue Zhang; Yi Zhang; Junyang Zhao; Xiaoyu Zheng; Katsiaryna Zhilyaeva; Nida Zia; Othman A O Ziko; Marcia Zondervan; Richard Bowman
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777

2.  The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.

Authors: 
Journal:  Lancet Glob Health       Date:  2022-08       Impact factor: 38.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.